At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
Distribution & Commercialization Services
Education & Reimbursement Support
Spotlight on Biosimilars
Biosimilar Pipeline Report
A guide for understanding the growing market
State of Biosimilars
a presentation on the biosimilars market
The Changing Biosimilar Landscape
In partnership with fierce pharma
New Podcast Episode - Biosimilars: Patents, policy, and reimbursement
Biosimilars Check Up: Part 2
“The recent pandemic state produced a spotlight on the need to drive savings within the U. S. pharmaceutical market – biosimilars are one of many solutions to reducing downstream cost. The importance of staying diligent and continuing to drive choice, access and savings is a top priority at AmerisourceBergen.”
Resources & Education
Read the FDA's guidance on biosimilars and get answers to patients' frequently asked questions.